Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (248)
  3. Review (13)
  4. Guidelines (11)
  5. Research Letter (9)
  6. Book Section (6)
  7. Correspondence (5)
  8. Editorial (4)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (671)
  2. Department of Medicine (671)
  3. Hematologic Malignancies, Division of (671)
  4. Lymphoma (671)
  5. Population Sciences Research Program (671)
  6. Survivorship Research (173)

More Groups

People
  1. Alison Moskowitz (235)
  2. Andrew Zelenetz (169)
  3. Paul Hamlin (140)
  4. Ariela Noy (139)
  5. David Straus (122)
  6. Maria Palomba (112)

More People

Years
  1. 2025 (18)
  2. 2024 (51)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Blood Advances (19)
  5. Leukemia and Lymphoma (19)
  6. Annals of Oncology (18)

More Publications

Publishers
  1. American Society of Hematology (277)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (34)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (23)

More Publishers

Results (671)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining progression free survival after multiple lines of therapy and impact of dynamic changes in FLIPI for multiply relapsed follicular lymphoma in the rituximab era
    Meeting Abstract

    Batlevi, C.; Alperovich, A.; Ni, A.; Soumerai, J.; Smith, K.; Ying, Z.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Time from prognosis to 2nd treatment is a promising surrogate for overall survival in patients with advanced stage follicular lymphoma
    Meeting Abstract

    Soumerai, J. D.; Ni, A.; Batlevi, C.; Alperovich, A.; Bantilan, K. S.; Palomba, M.; Gerecitano, J. F.; Noy, A.; Hamlin, P.; Moskowitz, C. H.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin vs physician's choice in CTCL patients from the Phase 3 ALCANZA study: Analysis of outcomes by CD30 expression
    Meeting Abstract

    Kim, Y. H.; Prince, H. M.; Whittaker, S.; Horwitz, S. M.; Duvic, M.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; Wolter, P.; Bechter, O.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Improved survival outcomes for patients with extra-nodal NK/T lymphoma: Data from 140 patients prospectively registered in the international T-cell project
    Meeting Abstract

    Fox, C. P.; Bellei, M.; Manni, M.; Kim, S. J.; Ko, Y. H.; Shustov, A. R.; Cabrera, M. E.; Chiattone, C. S.; Horwitz, S. M.; Spina, M.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
    Meeting Abstract

    Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/IB dose escalation and expansion of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C.; Hamlin, P.; Matasar, M.; Gerecitano, J.; Drullinsky, P.; Hamilton, A.; Straus, D.; Horwitz, S.; Kumar, A.; Moskowitz, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Primary cutaneous marginal zone lymphoma with leptomeningeal involvement and a durable response to rituximab
    Journal Article

    Virmani, P.; Busam, K.; Myskowski, P. L.; Yang, A.; Magro, C.; Horwitz, S.
    JAAD Case Reports (2017)

    Fulltext@MSK | Save
  • T-cell lymphoma: Recent advances in characterization and new opportunities for treatment
    Journal Article

    Casulo, C.; O'Connor, O.; Shustov, A.; Fanale, M.; Friedberg, J. W.; Leonard, J. P.; Kahl, B. S.; Little, R. F.; Pinter-Brown, L.; Advani, R.; more...
    JNCI: Journal of the National Cancer Institute (2017)

    Fulltext@MSK | Save
  • Analysis of peripheral T-cell lymphoma diagnostic workup in the United States
    Journal Article

    Hsi, E. D.; Horwitz, S. M.; Carson, K. R.; Pinter-Brown, L. C.; Rosen, S. T.; Pro, B.; Federico, M.; Gisselbrecht, C.; Schwartz, M.; Bellm, L. A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017
    Journal Article

    Wierda, W. G.; Zelenetz, A. D.; Gordon, L. I.; Abramson, J. S.; Advani, R. H.; Andreadis, C. B.; Bartlett, N.; Byrd, J. C.; Caimi, P.; Fayad, L. E.; more...
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save